Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Core Insights - Avadel Pharmaceuticals plc will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2025, at 10:30 a.m. ET [1] - A live webcast and an archived recording of the fireside chat will be available on Avadel's Investor Relations website for 90 days post-conference [2] Company Overview - Avadel Pharmaceuticals plc is a biopharmaceutical company focused on transforming medicines to improve patient lives [3] - The company’s commercial product, LUMRYZ™, is the first and only once-at-bedtime oxybate approved by the FDA for treating cataplexy or excessive daytime sleepiness in patients aged 7 years and older with narcolepsy [3]